Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brain Uptake of AH110690 (18F) in Alzheimer's and MCI
NCT00785759Phase 2Completed
- Sponsor
- GE HealthCare
- Start
- Sep 2008
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of flutemetamol, sponsored by GE HealthCare. Primary endpoint: Visual assessment of raised [18F] brain uptake. Started Sep 2008; status: completed.
02
Drugs
flutemetamol
Beyond the preview
Go deeper on NCT00785759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00785759.